Publicacions en col·laboració amb investigadors/es de Hammersmith Hospital (34)

2024

  1. Multidisciplinary Delphi Consensus on Safety of Combining Transarterial Radioembolization with Yttrium-90 Microspheres with Systemic Anticancer Agents for the Treatment of Liver Malignancy

    Journal of Vascular and Interventional Radiology, Vol. 35, Núm. 9, pp. 1253-1267.e1

  2. Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease

    Journal for ImmunoTherapy of Cancer, Vol. 12, Núm. 4

2023

  1. Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study

    The Lancet. Oncology, Vol. 24, Núm. 12, pp. 1411-1422

  2. The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022

    ESMO Open, Vol. 8, Núm. 3

2022

  1. Astrogliosis in aging and Parkinson's disease dementia: a new clinical study with 11C-BU99008 PET

    Brain Communications, Vol. 4, Núm. 5

  2. De Novo Malignancy after Liver Transplantation: Risk Assessment, Prevention, and Management - Guidelines from the ILTS-SETH Consensus Conference

    Transplantation, Vol. 106, Núm. 1, pp. E30-E45

  3. Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery

    BJS Open, Vol. 6, Núm. 1

2021

  1. ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors

    International Journal of Gynecological Cancer, Vol. 31, Núm. 7, pp. 961-982

  2. ESGO/ISUOG/IOTA/ESGE Consensus Statement on preoperative diagnosis of ovarian tumors

    Ultrasound in Obstetrics and Gynecology

  3. Elective Cancer Surgery in COVID-19-Free Surgical Pathways during the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study

    Journal of Clinical Oncology, Vol. 39, Núm. 1, pp. 66-78

  4. Parkinson’s disease laterality: a 11C-PE2I PET imaging study

    Journal of Neurology, Vol. 268, Núm. 2, pp. 582-589

  5. Pressure injury prediction models for critically-ill patients should consider both the case-mix and local factors

    Intensive and Critical Care Nursing

2018

  1. Is there a role for HIPEC in ovarian cancer?

    Archives of Gynecology and Obstetrics

  2. Peri-operative Management of the Obese Diabetic Patient

    Core Topics in Anaesthesia and Peri-operative Care of the Morbidly Obese Surgical Patient (Cambridge University Press), pp. 186-188

2017

  1. Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson's disease

    Scientific Reports, Vol. 7, Núm. 1

  2. First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

    The Lancet Oncology, Vol. 18, Núm. 9, pp. 1159-1171

  3. Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation

    Bone Marrow Transplantation, Vol. 52, Núm. 3, pp. 372-380

  4. Safety of selective internal radiation therapy (SIRT) with yttrium-90 microspheres combined with systemic anticancer agents: Expert consensus

    Journal of Gastrointestinal Oncology, Vol. 8, Núm. 6, pp. 1079-1099

2015

  1. Cost-effectiveness of selective internal radiation therapy using yttrium-90 resin microspheres in treating patients with inoperable colorectal liver metastases in the UK

    Journal of Medical Economics, Vol. 18, Núm. 10, pp. 797-804

2012

  1. Integrating radioembolization ( 90Y Microspheres) into current treatment options for liver tumors: Introduction to the international working group report

    American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 35, Núm. 1, pp. 81-90